Previous studies have identified Lyn and SHIP-1 as critical negative regulators of signaling in bone-marrow-derived immune cells, whereby their disruption can drive immunological diseases such as lupus and lung inflammation [11,12,13,14]. The gene discussed is LYN; the disease is systemic lupus erythematosus.